Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Chimeric Therapeutics Ltd. ( (AU:CHM) ).
Chimeric Therapeutics has announced the opening of its Entitlement Offer, which aims to raise approximately $3.2 million. This offer, which includes a non-renounceable pro rata entitlement of new shares and options, is expected to impact the company’s financial standing and market positioning positively.
More about Chimeric Therapeutics Ltd.
Chimeric Therapeutics Limited is an Australian company specializing in cell therapy. It focuses on developing innovative treatments in the biotechnology sector, aiming to enhance its market presence in the therapeutic industry.
Technical Sentiment Signal: Buy
Current Market Cap: A$11.34M
Learn more about CHM stock on TipRanks’ Stock Analysis page.